Analystreport

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at BMO Capital Markets from $182.00 to $183.00.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview